The US Food and Drug Administration (FDA) on Friday approved nivolumab and hyaluronidase-nvhy, under the trade name Opdivo ...

The US Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab-jsgr), in combination with platinum and ...

The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the use of Hyqvia (immune globulin infusion 10% [human ...

Akums secures a strategic deal to manufacture and supply oral liquid formulations for a global pharma company in Europe. The ...

Inmagene Biopharmaceuticals merges with Ikena Oncology to form InmageneBio, focusing on IMG-007, an OX40-targeting antibody ...

AusperBio raises $73 million in series B funding to advance Phase II trials of AHB-137, its antisense oligonucleotide therapy ...

Mumbai, India-based Mankind Pharma has entered into a partnership with China’s Innovent Biologics for exclusively licensing ...

The US Food and Drug Administration (FDA) has issued the Federal Register notice, Modifications to Labeling of ...

Japanese drugmaker Kaken Pharmaceutical has entered into a license agreement with US healthcare giant Johnson & Johnson for ...

US pharma major Eli Lilly today announced the US Food and Drug Administration (FDA) approved Zepbound its (tirzepatide) as ...

Viatris faces US FDA regulatory action on its Indore, India facility, with a warning letter and import alert restricting 11 ...

Denmark introduces a three-year agreement to regulate price ceilings for hospital medicines, with phased reductions totaling ...